Micropaque (Barium Sulfate)

Micropaque is a barium‑based contrast agent used for gastrointestinal radiographic examinations.

• Barium swallow: visualizes the esophagus and detects structural abnormalities.
• Barium meal: outlines the stomach and duodenum for assessment of mucosal lesions.
• Barium enema: delineates the colon to identify polyps, strictures or inflammatory changes.
• Upper GI series: provides comprehensive imaging of the esophagus, stomach and duodenum in a single study.

• Barium sulfate consists of insoluble, high‑atomic‑number particles that remain within the gastrointestinal lumen after oral administration. The dense barium attenuates X‑ray photons, creating a radiopaque coating that highlights the contour of the GI tract on fluoroscopic or plain radiographic images, thereby enhancing diagnostic visualization without systemic absorption.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate discomfort after ingestion.
• Abdominal cramping: intermittent pain during bowel movement of barium.
• Vomiting: occasional expulsion of the suspension.
• Diarrhea: loose stools as the barium passes through.
• Constipation: delayed transit leading to hard stools.
• Transient taste alteration: metallic or chalky aftertaste.

Serious or Rare Side Effects

• Aspiration pneumonitis: inhalation of barium causing lung inflammation.
• Severe allergic reaction (anaphylaxis): rare but requires immediate medical attention.
• Barium impaction: blockage of the bowel, especially in patients with strictures.
• Perforation risk: if a pre‑existing gastrointestinal lesion is present, barium may exacerbate injury.
• Electrolyte imbalance: rare, due to extensive fluid shifts.
• Persistent abdominal pain: may indicate obstruction or irritation.

Prior to using Micropaque, several safety considerations should be observed.

• Assess for gastrointestinal obstruction: avoid use in patients with known strictures or perforations.
• Check for hypersensitivity: discontinue if allergic reaction occurs.
• Ensure adequate hydration: promote clearance of barium from the GI tract.
• Avoid use in recent bowel surgery patients unless cleared by a surgeon.
• Pregnancy and lactation: use only if clearly needed, as safety has not been established.
• Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Micropaque can interact with other agents that affect gastrointestinal function or imaging interpretation.

Major Interactions (Avoid)

• Concurrent oral iodine‑based contrast agents: may interfere with radiographic assessment.
• Medications that reduce GI motility (e.g., anticholinergics, opioids): increase risk of barium retention.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: may alter suspension consistency.
• Chelating agents: could affect barium dispersion.
• Radiopharmaceuticals: timing should be coordinated to avoid overlapping imaging studies.